AI assistant
CERILLION PLC — Director's Dealing 2021
Jun 10, 2021
7556_dirs_2021-06-10_e3077168-f474-4a06-97db-16621ac1eb41.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 5103B
Cerillion PLC
10 June 2021
AIM: CER
Cerillion plc
("Cerillion" or "the Company")
Director/PDMR shareholding
Cerillion plc, the billing, charging and customer relationship management software solutions provider, announces that it has been notified that Mr. Andrew Smith, Marketing Director, and his wife Mrs. Katherine Smith, each sold 6,000 ordinary shares of GBP 0.005 each in the capital of the Company ("Ordinary Shares") at prices of 826 pence per Ordinary Share and 828.22 pence per Ordinary Share respectively on 9 June 2021.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the shares sold.
For further information please contact:
| Cerillion plc Louis Hall, CEO, Oliver Gilchrist, CFO |
c/o KTZ Communications T: 020 3178 6378 |
|
| Liberum (Nomad and Broker) | T: 020 3100 2000 | |
| Bidhi Bhoma, Euan Brown, William Hall | ||
| KTZ Communications | T: 020 3178 6378 | |
| Katie Tzouliadis, Dan Mahoney |
About Cerillion
Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management, with a 21-year track record in providing comprehensive revenue and customer management solutions. The Company has 90 customers across 44 countries, principally serving the telecommunications market.
The Company is headquartered in London and also has operations in Pune, Miami and Sydney.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Andrew Smith
2
Reason for the notification
a)
Position/status
Marketing Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Cerillion PLC
b)
LEI
213800ISIZMUC3P46850
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.005 each
GB00BYYX6C66
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 826 pence | 6,000 |
d)
Aggregated information
- Aggregated volume
- Price
Not Applicable - Single Transaction
e)
Date of the transaction
9 June 2021
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Katherine Smith
2
Reason for the notification
a)
Position/status
PCA of Andrew Smith, Marketing Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Cerillion PLC
b)
LEI
213800ISIZMUC3P46850
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.005 each
GB00BYYX6C66
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 828.22 pence | 6,000 |
d)
Aggregated information
- Aggregated volume
- Price
Not Applicable - Single Transaction
e)
Date of the transaction
9 June 2021
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEAEKEFDLFEFA